{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-21-000027","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2021-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.066789+00:00","generated_at":"2026-06-29T19:40:48.149556+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ICU Medical wins arbitration; Pfizer not entitled to up to $225M earn-out from 2017 Hospira deal","bullets":["Arbitrator ruled on August 7, 2021 that performance targets for HIS earn-out liability were not met.","Pfizer disputed ICU Medical's determination that the $191.3M to $225.0M earn-out was not payable.","Pfizer received no payment in connection with the earn-out liability under the Restated Purchase Agreement.","The dispute arose from the January 2017 acquisition of Pfizer's Hospira Infusion Systems business."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-21-000027","json":"https://secwatch.observer/filing/0000883984-21-000027.json","markdown":"https://secwatch.observer/filing/0000883984-21-000027.md","text":"https://secwatch.observer/filing/0000883984-21-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/0000883984-21-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/icui-20210807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T19:40:48.149556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}